1. Home
  2. ONCY vs VTIX Comparison

ONCY vs VTIX Comparison

Compare ONCY & VTIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$0.94

Market Cap

98.7M

Sector

Health Care

ML Signal

HOLD

Logo Virtuix Holdings Inc. Class A Common Stock

VTIX

Virtuix Holdings Inc. Class A Common Stock

N/A

Current Price

$2.88

Market Cap

109.9M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
ONCY
VTIX
Founded
1998
2013
Country
Canada
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Computer peripheral equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
98.7M
109.9M
IPO Year
2002
N/A

Fundamental Metrics

Financial Performance
Metric
ONCY
VTIX
Price
$0.94
$2.88
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$7.33
N/A
AVG Volume (30 Days)
1.6M
201.0K
Earning Date
05-08-2026
08-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2,505.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.71
$2.70
52 Week High
$1.51
$9.00

Technical Indicators

Market Signals
Indicator
ONCY
VTIX
Relative Strength Index (RSI) 52.82 37.37
Support Level $0.90 N/A
Resistance Level $1.06 $4.51
Average True Range (ATR) 0.06 0.35
MACD 0.01 -0.04
Stochastic Oscillator 62.80 23.08

Price Performance

Historical Comparison
ONCY
VTIX

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.

About VTIX Virtuix Holdings Inc. Class A Common Stock

Virtuix Holdings Inc develops technologies for immersive virtual environments, including both simulated and real-world applications. It develops virtual reality hardware and software, including the Omni Pro, an omni-directional treadmill designed to allow users to walk and run in multiple directions inside video games and other virtual worlds. The company operates at the intersection of gaming, fitness, and enterprise virtual reality. It has commercialized three products. The company operates in a single operating segment: the design, development, marketing, and sale of omni-directional treadmills, accessories, and related services to consumer and commercial customers. It derives revenue through a combination of hardware sales and recurring software and service income.

Share on Social Networks: